{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-007397","form_type":"8-K","ticker":"ATR","cik":"0000896622","company_name":"APTARGROUP, INC.","filed_at":"2022-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.237577+00:00","generated_at":"2026-06-27T16:05:39.084840+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Aptar appoints Gael Touya as President of Pharma Segment; board classes rebalanced","bullets":["Effective Jan 1, 2022, Gael Touya appointed President of Pharma Segment, reporting to CEO Stephan Tanda.","Touya will be based in Congers, NY, on a 3-year assignment (max 5 years).","Compensation includes expatriate benefits: housing, car, education, travel, tax equalization.","His French employment contract with Aptar Europe Holding SAS suspended for assignment duration.","Board rebalanced classes after death of director Joanne Smith; Candace Matthews shifted to 2023 term."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-007397","json":"https://secwatch.observer/filing/0001104659-22-007397.json","markdown":"https://secwatch.observer/filing/0001104659-22-007397.md","text":"https://secwatch.observer/filing/0001104659-22-007397.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/896622/000110465922007397/0001104659-22-007397-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/896622/000110465922007397/tm224376d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T16:05:39.084840+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}